3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
4
Active not recruiting
4
Withdrawn
1
Unknown
1
Terminated
1
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Carcinoma, Intraductal, Noninfiltrating
1
Breast Neoplasms
1
Interventions
Drug Therapy
108
Cisplatin
96
Radiotherapy
87
Carboplatin
84
Bevacizumab
81
Oxaliplatin
72
tislelizumab
69
Capecitabine
67
Cyclophosphamide
65
Gemcitabine
63
toripalimab
60
Paclitaxel
59
sintilimab
55
Specimen Handling
55
pembrolizumab
54
Surgical Procedures, Operative
51
Magnetic Resonance Spectroscopy
49
Fluorouracil
48
anlotinib
47
Immune Checkpoint Inhibitors
45
Blood Specimen Collection
42
130-nm albumin-bound paclitaxel
42
Standard of Care
37
camrelizumab
36
lenvatinib
34
fludarabine
34
Radiosurgery
33
Leucovorin
32
venetoclax
30
Immunotherapy
30
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
OTHER
×
FAPI-46
×
Clear all
NCT06540872
2024-08-06
MI-CISDIR
Universität Münster
Phase 2
Not yet recruiting
30 enrolled